Position
Parallel Advisors, LLC in Sagimet Biosciences Inc.
Back to the book · All holders of SGMT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$590$5.92 → $5.22
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 849 | $5.03K | — | — | — | 0.0% |
| Q1 2026 | 849 | $4.44K | $5.22 | −$590 | $0 | 0.0% |